Literature DB >> 5708315

Studies on tsushimycin. I. Isolation and characterization of an acidic acylpeptide containing a new fatty acid.

J I Shoji, S Kozuki, S Okamoto, R Sakazaki, H Otsuka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5708315

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  6 in total

1.  Crystallomycin revisited after 60 years: aspartocins B and C.

Authors:  Anton P Tyurin; Vera A Alferova; Alexander S Paramonov; Maxim V Shuvalov; Irina A Malanicheva; Natalia E Grammatikova; Pavel N Solyev; Shaowei Liu; Chenghang Sun; Igor A Prokhorenko; Tatyana A Efimenko; Larisa P Terekhova; Olga V Efremenkova; Zakhar O Shenkarev; Vladimir A Korshun
Journal:  Medchemcomm       Date:  2018-02-27       Impact factor: 3.597

Review 2.  Mechanism of Action and Resistance to Daptomycin in Staphylococcus aureus and Enterococci.

Authors:  William R Miller; Arnold S Bayer; Cesar A Arias
Journal:  Cold Spring Harb Perspect Med       Date:  2016-11-01       Impact factor: 6.915

Review 3.  The calcium-dependent lipopeptide antibiotics: structure, mechanism, & medicinal chemistry.

Authors:  Thomas M Wood; Nathaniel I Martin
Journal:  Medchemcomm       Date:  2019-03-21       Impact factor: 3.597

4.  Molecular cloning and identification of the laspartomycin biosynthetic gene cluster from Streptomyces viridochromogenes.

Authors:  Yang Wang; Ying Chen; Qirong Shen; Xihou Yin
Journal:  Gene       Date:  2011-05-27       Impact factor: 3.688

5.  The effect of tsushimycin on the synthesis of lipid-linked saccharides in aorta.

Authors:  A D Elbein
Journal:  Biochem J       Date:  1981-02-01       Impact factor: 3.857

6.  The lipopeptide antibiotic Friulimicin B inhibits cell wall biosynthesis through complex formation with bactoprenol phosphate.

Authors:  T Schneider; K Gries; M Josten; I Wiedemann; S Pelzer; H Labischinski; H-G Sahl
Journal:  Antimicrob Agents Chemother       Date:  2009-01-21       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.